Biocept Inc

OTC: BIOCQ    
Share price (4/23/24): $0.00    
Market cap (4/23/24): $263
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10
from 10-K 3 pages Biocept, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10
from 10-K 9 pages Darrell Taylor, Esq. 1345 Belleview Avenue Cardiff, Ca 92007 Re: Offer of Employment Dear Darrell: Biocept, Inc. (The “Company”) Is Pleased to Offer You At-Will Employment in the Position of Chief Legal and Compliance Officer (“Clo”) on the Terms and Conditions Set Forth in This Letter Agreement (The “Agreement”). 1
12/34/56
EX-10.1
from 8-K 8 pages Purchase Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Second Amendment to Assignment and Exclusive Cross-License Agreement
12/34/56
EX-10.1
from 10-Q 45 pages Biocept, Inc. Amended and Restated 2013 Equity Incentive Plan
12/34/56
EX-10.20
from 10-K 8 pages February 15, 2022 Timothy Kennedy Timken1212@gmail.com
12/34/56
EX-10.19
from 10-K 9 pages Material contract
12/34/56
EX-10.16
from 10-K 2 pages Biocept, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.15
from 10-K 3 pages First Amendment to Employment Agreement
12/34/56
EX-10.8
from 10-K 45 pages Biocept, Inc. Amended and Restated 2013 Equity Incentive Plan
12/34/56
EX-10.1
from 8-K 12 pages March 4, 2022 Philippe Marchand, PH.D. Re: Offer of Employment Dear Philippe: Biocept, Inc. (The “Company”) Is Pleased to Offer You At-Will Employment in the Position of Chief Operations Officer (“COO”) on the Terms and Conditions Set Forth in This Letter Agreement (The “Agreement”)
12/34/56
EX-10.2
from 8-K 12 pages February 15, 2022 Re: Offer of Employment Dear Antonino: Biocept, Inc. (The “Company”) Is Pleased to Offer You At-Will Employment in the Position of Interim Chief Financial Officer (“Interim CFO”) on the Terms and Conditions Set Forth in This Letter Agreement (The “Agreement”)
12/34/56
EX-10.1
from 8-K 12 pages February 15, 2022 Re: Offer of Employment Dear Samuel: Biocept, Inc. (The “Company”) Is Pleased to Offer You At-Will Employment in the Position of Interim Chief Executive Officer (“Interim CEO”) on the Terms and Conditions Set Forth in This Letter Agreement (The “Agreement”)
12/34/56
EX-10.2
from 10-Q 41 pages Biocept, Inc. Amended and Restated 2013 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 13 pages Employment Agreement
12/34/56
EX-10.7
from 10-Q 12 pages Employment Agreement
12/34/56
EX-10.6
from 10-Q 12 pages First Amendment to Employment Agreement
12/34/56
EX-10.4
from 10-Q 3 pages Fifth Amendment to Lease
12/34/56
EX-10.3
from 10-Q 44 pages Single-Tenant Lease (Triple Net) Landlord: 9955 Mesa Rim, a De LLC, a Delaware Limited Liability Company Tenant: Biocept, Inc., a Delaware Corporation
12/34/56
EX-10.1
from 8-K 4 pages Amendment to Warrant Exercise Agreement
12/34/56